AH Bio Fund IV, L.P., 10% Owner at Braveheart Bio, Inc. (BRVE), bought 1,100,000 shares at $18.00 ($19.8M) on 2026-08-07, disclosed to the SEC on 2026-08-11.
AH Bio Fund IV, L.P. purchased 1.1 million shares for $19.8 million at $18.00 per share, marking the largest insider purchase in the company's history. This significant buyback by a major shareholder suggests confidence in the company's recent IPO and future growth prospects.
Insufficient data — needs manual review
Insufficient data — needs manual review
Negative factors outweigh the positive ones.